Prostate Androgen Response Investigation Using a Stratification BIOmarker; Predicting Prostate Cancer Downstaging by Neoadjuvant Darolutamide With PCAI ImmunoScore

Clinical trial NCT07617272 · RECRUITING

Trial details

NCT number: NCT07617272
Sponsor: Region Stockholm
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer (Adenocarcinoma)

Start date: 2025-11-09
Primary completion: 2027-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.